Antisoma

The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
clinical trials
dimebon
Medivation
Pfizer
ocrelizumab
Roche
rheumatoid arthritis
taspoglutide
diabetes
Ipsen
semagacestat
Eli Lilly
ASA404
Antisoma
Novartis
Novelos Therapeutics
AstraZeneca
zibotentan
vicriviroc
Merck
Recentin
Vical
Sanofi
Antisoma plunges as late-stage lung-cancer-drug trial halted
Marketwatch
Mon, 03/29/10 - 10:14 am
Antisoma
lung cancer
Antisoma abandons Phase II breast cancer drug
Reuters
Fri, 08/7/09 - 11:16 am
Antisoma
breast cancer
drug trials
Antisoma to Sell U.S. Rights to Leukemia Drug by June
Bloomberg
Mon, 01/26/09 - 11:33 am
Antisoma
cancer
leukemia